Literature DB >> 30893549

Overcoming the Challenges of Enzyme Evolution To Adapt Phosphotriesterase for V-Agent Decontamination.

Andrew N Bigley1, Emily Desormeaux1, Dao Feng Xiang1, Sue Y Bae2, Steven P Harvey2, Frank M Raushel1.   

Abstract

The bacterial enzyme phosphotriesterase (PTE) is noted for its ability to hydrolyze many organophosphate compounds, including insecticides and chemical warfare agents. PTE has been the subject of multiple enzyme evolution attempts, which have been highly successful against specific insecticides and the G-type nerve agents. Similar attempts targeting the V-type nerve agents have failed to achieve the same degree of success. Enzyme evolution is an inherently complex problem, which is complicated by synergistic effects, the need to use analogues in high-throughput screening, and a lack of quantitative data to direct future efforts. Previous evolution experiments with PTE have assumed an absence of synergy and minimally screened large libraries, which provides no quantitative information about the effects of individual mutations. Here a systemic approach has been applied to a 28800-member six-site PTE library. The library is screened against multiple V-agent analogues, and a combination of sequence and quantitative activity analysis is used to extract data about the effects of individual mutations. We demonstrate that synergistic relationships dominate the evolutionary landscape of PTE and that analogue activity profiles can be used to identify variants with high activity for substrates. Using these approaches, multiple variants with kcat/ Km values for the hydrolysis of VX that were improved >1500-fold were identified, including one variant that is improved 9200-fold relative to wild-type PTE and is specific for the SP enantiomer of VX. Multiple variants that were highly active for ( SP)-VR were identified, the best of which has a kcat/ Km values that is improved 13400-fold relative to that of wild-type PTE.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30893549     DOI: 10.1021/acs.biochem.9b00097

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Stereoselective Formation of Multiple Reaction Products by the Phosphotriesterase from Sphingobium sp. TCM1.

Authors:  Andrew N Bigley; Tamari Narindoshvili; Dao Feng Xiang; Frank M Raushel
Journal:  Biochemistry       Date:  2020-03-17       Impact factor: 3.162

2.  Substrate Analogues for the Enzyme-Catalyzed Detoxification of the Organophosphate Nerve Agents-Sarin, Soman, and Cyclosarin.

Authors:  Andrew N Bigley; Steven P Harvey; Tamari Narindoshvili; Frank M Raushel
Journal:  Biochemistry       Date:  2021-09-08       Impact factor: 3.321

Review 3.  Enhancing organophosphate hydrolase efficacy via protein engineering and immobilization strategies.

Authors:  Priya Katyal; Stanley Chu; Jin Kim Montclare
Journal:  Ann N Y Acad Sci       Date:  2020-08-19       Impact factor: 5.691

4.  Enzyme-Catalyzed Kinetic Resolution of Chiral Precursors to Antiviral Prodrugs.

Authors:  Dao Feng Xiang; Andrew N Bigley; Emily Desormeaux; Tamari Narindoshvili; Frank M Raushel
Journal:  Biochemistry       Date:  2019-07-10       Impact factor: 3.162

Review 5.  Enzymatic Bioremediation of Organophosphate Compounds-Progress and Remaining Challenges.

Authors:  Meghna Thakur; Igor L Medintz; Scott A Walper
Journal:  Front Bioeng Biotechnol       Date:  2019-11-08

6.  Steady-State Kinetics of Enzyme-Catalyzed Hydrolysis of Echothiophate, a P-S Bonded Organophosphorus as Monitored by Spectrofluorimetry.

Authors:  Irina V Zueva; Sofya V Lushchekina; David Daudé; Eric Chabrière; Patrick Masson
Journal:  Molecules       Date:  2020-03-17       Impact factor: 4.411

7.  A Chemoenzymatic Synthesis of the (RP)-Isomer of the Antiviral Prodrug Remdesivir.

Authors:  Andrew N Bigley; Tamari Narindoshvili; Frank M Raushel
Journal:  Biochemistry       Date:  2020-08-10       Impact factor: 3.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.